Clinical trial
Phase III Clinical Trial to Evaluate the Efficacy and Safety of DWKH
NCT05683951 is registered in ClinicalTrials.gov with Daewon Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase III Clinical Trial to Evaluate the Efficacy and Safety of DWKH
- Lead sponsor
- Daewon Pharmaceutical Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 26, 2021
- Completion date
- December 16, 2022
- Enrollment
- 186 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
respiratory infection